Exenatide is a GLP-1 agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist ...

“You might get lucky, man,” Shoemyer said. “We were less than one quarter of 1%, and things have been counted wrong. You know, mistakes have been made.” The backers of Amendment 2 are ...

Disposable syringes with improved ergonomics and ease of use are increasingly used. For example, in September 2020, BD launched Maxxdose pre-filled 3 mL and 5 mL syringes with an improved handle ...

Perpetual license revenue was $2.9 million in the third quarter of 2024, compared to $4.1 million in the third quarter of 2023. Total revenue was $240.1 million in the third quarter of 2024 ...

Spotify is on course to achieve its first-ever full year as a profitable company – to the tune of USD $1.5 billion. The company yesterday (November 12) published its financial results and user numbers ...

That's down from $975 million during the third quarter of 2023. The Montreal-based management and holding company says net earnings per share were 58 cents, down from $1.47 during the same quarter ...

“It was a bang-up quarter across the board, that’s the only way to describe it,” Samad Samana, managing director at Jefferies, told BNN Bloomberg in a Tuesday interview. “You had robust growth across ...

(NASDAQ:MARA) ("MARA" or the "Company"), a global leader in leveraging digital asset compute to support the energy transformation, today announced that its third quarter 2024 financial results are ...

But Mercury's figures show the challenger increasing its market share by just 0.9 percent year-on-year, and just 0.1 percent over the previous quarter to 24.2 percent. Both AMD and Intel experienced ...

The threshold for a hand recount is when the difference is less than 150 votes apart and less than a quarter of 1% of the total number of votes cast for both candidates. The legislative session ...